Figure S5. The parameter estimation averaged over 100 replicates for grMCP, grSCAD, and cMCP for Scenario 4. Blue cycles denote the simulated non-zero values. Black points and lines represent the estimated values and the interval estimates of coefficients. The main title of each plot denotes the varying the number of non-null group for Scenario 4. (PDF 783 kb
Prediction measures of the selected models by the lasso penalty. Additional results of the simulatio...
Developed clinico-genomic model through the full biomarker-by-treatment interaction Cox model subjec...
Figure A2. Subgroup of OS2006 historical data (SARC-OS data). Observed Kaplan-Meier and parametric e...
Figure S1. The parameter estimation averaged over 100 replicates for the group spike-and-slab lasso ...
Figure S6. The parameter estimation averaged over 100 replicates for the group spike-and-slab lasso ...
Figure S2. The parameter estimation averaged over 100 replicates for the group spike-and-slab lasso ...
S7. The detected genes and their standardized effect sizes estimated by the group spike-and-slab las...
Figure S8. The solution path and cross-validated partial loglikelihood profiles of the group spike-a...
S4, S5 and S6. The pathway enrichment analyses for these detected genes for ovarian cancer, lung can...
Table S1. The measures of optimal group spike-and-slab lasso (gsslasso) cox and the lasso cox models...
S1, S2, and S3. The detailed information of genes shared by different pathways for ovarian cancer, l...
The P-value of the Cox univariate regression analysis using different gene sets. (A) The P-values of...
Table S1. TPR, FPR and FDR in variable selection with 50 replications (Weibull distribution). Table ...
Accuracy and precision of the survival probabilities, and coverage probability of the associated 95%...
Table S1. Title: 104 common survival-related genes were identified from patients with GBM and those ...
Prediction measures of the selected models by the lasso penalty. Additional results of the simulatio...
Developed clinico-genomic model through the full biomarker-by-treatment interaction Cox model subjec...
Figure A2. Subgroup of OS2006 historical data (SARC-OS data). Observed Kaplan-Meier and parametric e...
Figure S1. The parameter estimation averaged over 100 replicates for the group spike-and-slab lasso ...
Figure S6. The parameter estimation averaged over 100 replicates for the group spike-and-slab lasso ...
Figure S2. The parameter estimation averaged over 100 replicates for the group spike-and-slab lasso ...
S7. The detected genes and their standardized effect sizes estimated by the group spike-and-slab las...
Figure S8. The solution path and cross-validated partial loglikelihood profiles of the group spike-a...
S4, S5 and S6. The pathway enrichment analyses for these detected genes for ovarian cancer, lung can...
Table S1. The measures of optimal group spike-and-slab lasso (gsslasso) cox and the lasso cox models...
S1, S2, and S3. The detailed information of genes shared by different pathways for ovarian cancer, l...
The P-value of the Cox univariate regression analysis using different gene sets. (A) The P-values of...
Table S1. TPR, FPR and FDR in variable selection with 50 replications (Weibull distribution). Table ...
Accuracy and precision of the survival probabilities, and coverage probability of the associated 95%...
Table S1. Title: 104 common survival-related genes were identified from patients with GBM and those ...
Prediction measures of the selected models by the lasso penalty. Additional results of the simulatio...
Developed clinico-genomic model through the full biomarker-by-treatment interaction Cox model subjec...
Figure A2. Subgroup of OS2006 historical data (SARC-OS data). Observed Kaplan-Meier and parametric e...